FDA-approved drug helps treat rare immunologic disease, study finds
NIH co-funded clinical trial tested alternative treatment for eosinophilic syndrome.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: Allergy & Immunology | American Health | Clinical Trials | National Institutes of Health (NIH) | Study